TELA Bio, Inc. (NASDAQ: TELA) reported Q3 EPS of ($0.19), $0.03 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $20.7 million versus the consensus estimate of $22.23 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.